nifedipine has been researched along with Emesis in 6 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to compare the efficacy of intravenously administered hydralazine and oral nifedipine for acute blood pressure control in acute hypertensive emergency of pregnancy." | 9.24 | Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. ( Gupta, A; Sharma, C; Soni, A; Verma, A; Verma, S, 2017) |
| "We sought to compare the efficacy of intravenously administered hydralazine and oral nifedipine for acute blood pressure control in acute hypertensive emergency of pregnancy." | 5.24 | Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. ( Gupta, A; Sharma, C; Soni, A; Verma, A; Verma, S, 2017) |
| "Activation of serotonergic 5-HT3 receptors by its selective agonist 2-methyl serotonin (2-Me-5-HT) induces vomiting, which is sensitive to selective antagonists of both 5-HT3 receptors (palonosetron) and L-type calcium channels (LTCC) (amlodipine or nifedipine)." | 3.81 | L-type calcium channels contribute to 5-HT3-receptor-evoked CaMKIIα and ERK activation and induction of emesis in the least shrew (Cryptotis parva). ( Chebolu, S; Darmani, NA; Hutchinson, TE; Wilson, SM; Zhong, W, 2015) |
| "Diffuse esophageal spasm (DES) causes chest pain and/or dysphagia in adults." | 1.39 | Diffuse esophageal spasm in children referred for manometry. ( Cocjin, J; Hyman, PE; Lavenbarg, T; Rosen, JM, 2013) |
| "The hypertension resolved after the intussusception was reduced." | 1.30 | [Hypertensive manifestation of an acute intestinal intussusception]. ( Bourdat-Michel, G; Durand, C; Paget, C; Rossignol, AM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, C | 1 |
| Soni, A | 1 |
| Gupta, A | 1 |
| Verma, A | 1 |
| Verma, S | 1 |
| Darmani, NA | 2 |
| Zhong, W | 2 |
| Chebolu, S | 2 |
| Vaezi, M | 1 |
| Alkam, T | 1 |
| Hutchinson, TE | 1 |
| Wilson, SM | 1 |
| Rosen, JM | 1 |
| Lavenbarg, T | 1 |
| Cocjin, J | 1 |
| Hyman, PE | 1 |
| Arber, N | 1 |
| Grossman, A | 1 |
| Tiomny, E | 1 |
| Rattan, J | 1 |
| Kadish, U | 1 |
| Novis, B | 1 |
| Neuman, G | 1 |
| Lilos, P | 1 |
| Rozen, P | 1 |
| Gilat, T | 1 |
| Paget, C | 1 |
| Rossignol, AM | 1 |
| Durand, C | 1 |
| Bourdat-Michel, G | 1 |
1 trial available for nifedipine and Emesis
| Article | Year |
|---|---|
Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial.
Topics: Acute Disease; Adolescent; Adult; Apgar Score; Double-Blind Method; Emergencies; Female; Humans; Hyd | 2017 |
5 other studies available for nifedipine and Emesis
| Article | Year |
|---|---|
Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
Topics: Animals; Antiemetics; Calcium Channel Blockers; Calcium Channels, L-Type; Drug Synergism; Female; Is | 2014 |
L-type calcium channels contribute to 5-HT3-receptor-evoked CaMKIIα and ERK activation and induction of emesis in the least shrew (Cryptotis parva).
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Brain Stem; Calcium Channel Blockers; Calciu | 2015 |
Diffuse esophageal spasm in children referred for manometry.
Topics: Adolescent; Age Factors; Calcium Channel Blockers; Chest Pain; Child; Child, Preschool; Cohort Studi | 2013 |
Achalasia in central Israel, 1973-83: clinical aspects.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Deglutition Disorders; Dilatation; Esophageal Acha | 1994 |
[Hypertensive manifestation of an acute intestinal intussusception].
Topics: Acute Disease; Barium Sulfate; Calcium Channel Blockers; Enema; Humans; Hypertension; Infant; Intuss | 1999 |